GlobeNewswire: CBD Life Sciences Inc. Contains the last 10 of 60 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T02:51:54ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/09/19/1917905/0/en/CBD-Life-Sciences-Subsidiary-to-Launch-Natural-Hemp-CBD-Gummies-Product-Line.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary to Launch Natural Hemp CBD Gummies Product Line2019-09-19T12:00:00Z<![CDATA[SCOTTSDALE, AZ, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: CBDL) today announces that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), has finalized development of and is preparing to launch a line of natural hemp extract-infused CBD Gummies. The Gummies will be offered in a variety of flavors including strawberry, apple, blueberry, lemon and orange and contain 50 mg hemp extract per gummy.]]>https://www.globenewswire.com/news-release/2019/09/10/1913365/0/en/CBD-Life-Sciences-Subsidiary-in-Talks-to-Acquire-Land-for-Commercial-Hemp-Growing-Operation.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary in Talks to Acquire Land for Commercial Hemp Growing Operation2019-09-10T12:00:00Z<![CDATA[SCOTTSDALE, AZ, Sept. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: CBDL) today announced that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC Bioscience), has entered into negotiations to acquire a parcel of land in Mohave County, Arizona with the intent of commencing a commercial hemp growing operation. This strategic purchase will allow LBC Bioscience to grow its own hemp keeping complete control of key ingredients used in its products while providing additional revenue through the sale of hemp to third parties. The initial contract is for the purchase of 10 acres with the opportunity to acquire a total of 1,600. The seller also is offering turnkey hemp growing services along with site security management.]]>https://www.globenewswire.com/news-release/2019/07/16/1883256/0/en/CBD-Life-Sciences-Files-Initial-Reg-A-Offering-Statement.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Files Initial Reg A+ Offering Statement2019-07-16T12:00:00Z<![CDATA[SCOTTSDALE, AZ, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that it has filed an offering statement with the United States Securities Exchange Commission (SEC) to raise $10 million under a Regulation A+ securities offering. The net proceeds of this offering will be used to advance the CBD based product lines of its wholly owned subsidiary, LBC Bioscience and to establish a lab for research and development. By utilizing Regulation A+, CBD Life Sciences Inc. will make its securities available to investors who may not otherwise be able purchase nor qualify as accredited. The offering is being prices at $0.10 per share with a minimum allotment $1,000.]]>https://www.globenewswire.com/news-release/2019/07/09/1880060/0/en/CBD-Life-Sciences-Subsidiary-Developing-Line-of-CBD-Based-Coffee-Products-Including-Weight-Loss-Coffee-Brain-Booster.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary Developing Line of CBD Based Coffee Products Including Weight Loss Coffee & Brain Booster2019-07-09T12:00:00Z<![CDATA[SCOTTSDALE, AZ, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), has finalized the development and is preparing to launch a CBD infused line of coffee products for the US domestic market. The product line will initially consist of four products including a weight loss coffee and a brain booster. It is expected that the products will be available for purchase within the next three to four weeks.]]>https://www.globenewswire.com/news-release/2019/06/25/1873739/0/en/CBD-Life-Sciences-Subsidiary-Launches-Product-for-Equine-Market.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary Launches Product for Equine Market2019-06-25T12:00:00Z<![CDATA[SCOTTSDALE, AZ, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, has completed its formulation and is now marketing a CBD supplement for the equine market. The product is a blueberry flavored paste delivered orally via syringe very similar to existing products such as deworming pastes and other oral medications.]]>https://www.globenewswire.com/news-release/2019/06/18/1870234/0/en/CBD-Life-Sciences-Subsidiary-Continues-Significant-Revenue-Growth.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary Continues Significant Revenue Growth2019-06-18T12:00:00Z<![CDATA[SCOTTSDALE, ARIZONA, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), is continuing to experience significant revenue growth as a result of the expansion and market acceptance of its product lines.]]>https://www.globenewswire.com/news-release/2019/06/11/1866817/0/en/CBD-Life-Sciences-Subsidiary-Launching-Production-for-CBD-Vaping-Market.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary Launching Production for CBD Vaping Market2019-06-11T12:00:00Z<![CDATA[SCOTTSDALE, AZ, June 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, has completed the development of a disposable CBD vape-pen. The product is now undergoing final market testing and is expected to be available for purchase within the next three to four weeks.]]>LBC Bioscience CBD Vape PenCBD Life Sciences Inc.https://www.globenewswire.com/news-release/2019/04/18/1806428/0/en/CBD-Life-Sciences-Subsidiary-Enters-Into-Negotiations-to-Enter-Japanese-Market.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary Enters Into Negotiations to Enter Japanese Market2019-04-18T12:00:00Z<![CDATA[SCOTTSDALE, ARIZONA, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience has entered into negotiations to distribute its line of products in Japan. The negotiations are anticipated to close within the next two weeks with an initial order of $250,000.]]>https://www.globenewswire.com/news-release/2019/03/08/1750558/0/en/CBD-Life-Sciences-Subsidiary-LBC-Bioscience-Launches-CBD-Based-Anti-Aging-Product-Line.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary LBC Bioscience Launches CBD Based Anti-Aging Product Line2019-03-08T13:00:00Z<![CDATA[SCOTTSDALE, AZ, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE-- CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc., has now finalized the formulization for and is launching an organic - GMO free - CBD based anti-aging product line. The product line includes: anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream.]]>https://www.globenewswire.com/news-release/2019/02/27/1743574/0/en/CBD-Life-Sciences-Subsidiary-LBC-Bioscience-Sell-Out-at-Fountain-Hills-Great-Fair.html?f=22&fvtc=4&fvtv=43213CBD Life Sciences Subsidiary LBC Bioscience Sell Out at Fountain Hills Great Fair2019-02-27T15:43:07Z<![CDATA[SCOTTSDALE, AZ, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: OCSYD) is pleased to announce that its wholly owned subsidiary, LBC Bioscience Inc., completely sold out of all its products at the recently held Fountain Hills Great Fair, generating over $10,000 in sales in two days. Now in its 32nd year, the annual Fountain Hills Great Fair features over 500 select artisans from around the world offering unique products and one-of-a kind works. LBC Bioscience was 1 of 5 CBD exhibitors at the event.]]>